Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Pechkovsky, A. Prasse, J. Müller-Quernheim, G. Zissel (Minsk, Belarus; Freiburg, Germany). M2 polarized alveolar macrophages in pulmonary fibrosis. Eur Respir J 2005; 26: Suppl. 49, 1623

Member's Comments

No comment yet.

Related content which might interest you: The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 Alveolar epithelial injury and apoptosis Source: Annual Congress 2007 - Mechanisms in pulmonary fibrosis Year: 2007 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis Source: Eur Respir J 2012; 39: 297-304 Year: 2012 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006 Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 180-189 Year: 2001 Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages Source: Eur Respir J, 55 (1) 1900646; 10.1183/13993003.00646-2019 Year: 2020 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016